People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

60.28USD
30 Jan 2015
Change (% chg)

$-1.81 (-2.92%)
Prev Close
$62.09
Open
$61.56
Day's High
$61.93
Day's Low
$60.03
Volume
4,944,700
Avg. Vol
2,963,887
52-wk High
$63.62
52-wk Low
$51.93

Search Stocks

Cech, Thomas 

Brief Biography

Dr. Thomas R. Cech Ph.D., is an Independent Director of Merck & Co., Inc. He has been Investigator, Howard Hughes Medical Institute since 1988, and President from 2000 to 2009; Faculty, University of Colorado since 1978; Director, BioFrontiers Institute, University of Colorado since 2009. Trustee, Grinnell College; Member, National Academy of Sciences. Dr. Cech was also a director of Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.) from May to November 2009.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks